The linear quadratic model: usage, interpretation and challenges.
McMahon SJ.
Phys Med Biol. 2018 Dec 19;64(1):01TR01. doi: 10.1088/1361-6560/aaf26a.
Radiobiology of brachytherapy: The historical view based on linear quadratic model and perspectives for optimization.
Chargari C, Van Limbergen E, Mahantshetty U, Deutsch É, Haie-Méder C.
Cancer Radiother. 2018 Jun;22(4):312-318. doi: 10.1016/j.canrad.2017.11.011. Epub 2018 May 30.
Lymphocyte radiosensitivity: An extension to the linear-quadratic model?
Pham TN, Coupey J, Thariat J, Valable S.
Radiother Oncol. 2024 Sep;198:110406. doi: 10.1016/j.radonc.2024.110406. Epub 2024 Jun 24.
The use of the linear quadratic model in radiotherapy: a review.
Jones L, Hoban P, Metcalfe P.
Australas Phys Eng Sci Med. 2001 Sep;24(3):132-46. doi: 10.1007/BF03178355.
The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
van Leeuwen CM, Oei AL, Crezee J, Bel A, Franken NAP, Stalpers LJA, Kok HP.
Radiat Oncol. 2018 May 16;13(1):96. doi: 10.1186/s13014-018-1040-z.
A linear-quadratic model of cell survival considering both sublethal and potentially lethal radiation damage.
Rutz HP, Coucke PA, Mirimanoff RO.
Radiother Oncol. 1991 Aug;21(4):273-6. doi: 10.1016/0167-8140(91)90053-j.
The linear-quadratic model.
[No authors listed]
Br J Radiol. 1988 Aug;61(728):700-7. doi: 10.1259/0007-1285-61-728-700-b.
Use of the linear-quadratic radiobiological model for quantifying kidney response in targeted radiotherapy.
Dale R.
Cancer Biother Radiopharm. 2004 Jun;19(3):363-70. doi: 10.1089/1084978041425070.
Invalidity of, and alternative to, the linear quadratic model as a predictive model for postirradiation cell survival.
Li H.
Cancer Sci. 2023 Jul;114(7):2931-2938. doi: 10.1111/cas.15796. Epub 2023 Apr 5.
Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula.
Schneider U.
Med Phys. 2009 Apr;36(4):1138-43. doi: 10.1118/1.3089792.
